Cian Healthcare Limited , a company currently undergoing Corporate Insolvency Resolution Process (CIRP), has taken a significant step in its restructuring efforts. The Committee of Creditors (CoC) has approved the appointment of DMKH & Co. as the Transaction Auditor for the company's insolvency proceedings.

Appointment Details

The appointment of DMKH & Co. covers an extensive period from June 11, 2022, to August 14, 2024. The firm will receive a remuneration of INR 195,000.00, exclusive of applicable taxes and out-of-pocket expenses, for their services during this timeframe.

About DMKH & Co.

DMKH & Co., established in 1990, brings a wealth of experience to this role. With 35 years of expertise across various industries, the chartered accountancy firm is well-positioned to handle the complexities of Cian Healthcare's insolvency process.

Voting Process and Outcomes

The decision to appoint DMKH & Co. was made through an e-voting process conducted by the Committee of Creditors. Key points of the voting include:

Additional Resolution

In addition to the appointment of the Transaction Auditor, the Committee of Creditors approved a procedural change. The notice period for future meetings has been reduced from 4 days to 2 working days, potentially streamlining the decision-making process during the insolvency proceedings.

This development marks a crucial step in Cian Healthcare's ongoing Corporate Insolvency Resolution Process, with DMKH & Co. set to play a pivotal role in auditing transactions during this critical period.

Cian Healthcare , a company currently undergoing Corporate Insolvency Resolution Process (CIRP), has announced a significant development in its ongoing insolvency proceedings. The company's resolution plan, which was previously approved by the Committee of Creditors, is now set for a crucial hearing before the National Company Law Tribunal (NCLT) Mumbai Bench.

Key Developments

• The Committee of Creditors approved Cian Healthcare's resolution plan on May 9, 2025.
• The approved plan was submitted to the NCLT Mumbai Bench-VI on May 23, 2025.
• A hearing was held before the Hon'ble NCLT on August 6, 2025.
• The next hearing for consideration and approval of the resolution plan is scheduled for August 22, 2025.

Regulatory Compliance

In compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015, Cian Healthcare has been keeping its stakeholders and regulatory authorities informed about the ongoing CIRP. The company's disclosures align with the SEBI Master Circular dated November 11, 2024, as amended on December 31, 2024.

Management Statement

Roshen Chordiya, the Resolution Professional for Cian Healthcare Limited, stated in the company's BSE filing, "We shall continue to keep all stakeholders and regulatory authorities abreast of further material developments in this regard."

Company Background

Cian Healthcare Limited, an ISO 9001:2015 & WHO GMP Certified company, operates from its registered office in Pune and has a manufacturing facility in Uttarakhand.

As the insolvency resolution process progresses, stakeholders and industry observers will be closely watching the outcome of the August 22 hearing, which could potentially determine the future course for Cian Healthcare Limited.